Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abundant, abusive, Biomed, Biomedicine, Bitomed, Brissett, broke, carefully, CICC, coercive, Conference, consortium, construed, consummated, consummation, CSPC, detained, disallowed, discontinued, distorted, Duff, EBITDA, exiting, fell, Feng, Fuerde, Gao, Gotshal, GP, guard, Guatemala, Heng, improperly, intention, Isaly, isolation, Jilin, Jing, junior, Kuai, Le, Li, lieu, Luye, media, Merchant, microbiology, noncurrent, oversaw, Pharma, physiology, PKU, Programme, PSUR, Qiang, Qianhai, qualitative, redeem, renovation, reposted, repurchase, SA, Salvador, Samuel, scandal, Shandong, Sionvac, slowly, stake, stored, Subtopic, syringe, Timetable, underway, Unresolved, unused, visibility, Weil, withdrawal, Xing, Yi, Zhong
Removed:
accumulatively, adding, Asia, Asian, attempt, Avoidance, Bhd, Capitalization, CERTIFYING, channel, commissioning, comparing, decided, demonstrated, deterioration, diminished, display, disposed, dramatically, ease, East, element, essentially, field, Finally, foot, forecast, forecasted, GCP, Glovax, GLP, headquarter, HK, Hononary, impaired, imprecise, improvement, leasehold, machinery, Mexican, mouth, nonproduction, nonrecurring, occupancy, OFAC, originally, penetrate, permission, physical, preference, premise, preparing, Questmark, quota, rabend, rabid, recoverability, reducing, regulator, relocated, resale, revoked, Santai, Sdn, Shangpharma, shell, Simultaneously, South, supplementary, Tabular, tendering, training, transmission, travel, unexercisable, unknown, upgraded, USA, Vocational
Filing tables
Filing exhibits
SVA similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
i) | Registration Statement (Form S-8 No. 333-161827) pertaining to Sinovac Biotech Ltd.’s 2003 Stock Option Plan; and |
ii) | Registration Statement (Form S-8 No. 333-190980) pertaining to Sinovac Biotech Ltd.’s 2012 Share Incentive Plan; |
of our reports dated April 25, 2016, with respect to the consolidated financial statements of Sinovac Biotech Ltd. and the effectiveness of internal control over financial reporting of Sinovac Biotech Ltd., included in this Annual Report (Form 20-F) of Sinovac Biotech Ltd. for the year ended December 31, 2015.
/s/ Ernst & Young Hua Ming LLP | |
Beijing, The People’s Republic of China | |
April 25, 2016 |